Diplomat Specialty Pharmacy Makes Inc.’s Fast Growth List For 5th Straight Year
FLINT (WWJ) — Diplomat Specialty Pharmacy has made the list of Inc. Magazine’s fastest growing privately held companies for the fifth consecutive year.
Diplomat ranked third in the nation in the list’s health category for revenue, a jump from fourth in 2012, and its three-year growth rate was pegged at 199 percent — from $377.5 million in 2009 to $1.1 billion in 2012.
“Recognition on the Inc. 5000 list continues to be an important metric in gauging our overall growth,” said CEO Phil Hagerman, who co-founded Diplomat Specialty Pharmacy with his pharmacist father Dale Hagerman immediately following graduation from pharmacy school in 1975. “What is especially meaningful to the Diplomat team is we continue to grow the business and forge relationships with new health care industry partners while achieving sustained customer and physician satisfaction rates above 98 percent.”
With almost 500 jobs created between 2009 and 2012, Diplomat was cited by Inc. magazine in December 2012 as one of nation’s top 100 job creators. Looking forward, Hagerman foresees additional business and job growth.
“Diplomat remains on track to add a total of 1,000 new jobs between 2010 and 2015. We’ll need that increased capacity as projected specialty pharmacy purchases are projected to be 50 percent of the total drug spend by 2018,” said Hagerman.
Hagerman noted that even more important than job growth is Diplomat’s unwavering attention to patient care and its clinical mission to improve patient compliance and adherence as drug therapies grow more complex and costly, and often bring challenging side effects.
“The key to optimal patient compliance and adherence lies with patient education and training, packaging that keeps drugs safe and secure yet is easy for patients to open, side effect management kits, nurse adherence calls for clinical support and guidance, and adaptive technology, whether that be through smart phones, prescription bottles with glow caps or packaging with alarms and reminders,” Hagerman said. “Diplomat is a leader in these areas and we will continue to focus efforts on new approaches to compliance and adherence through our high-tech, high-touch patient strategy.”
Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region and other criteria, can be found at http://www.inc.com/5000.
Diplomat serves patients nationwide as the country’s largest independent specialty pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions, including cancer, AIDS, hepatitis, multiple sclerosis, arthritis, Crohn’s disease, hemophilia, growth hormone deficiency and psoriasis. Other specialty areas include transplant, fertility and bio-identical hormone therapy.
More at http://www.diplomatpharmacy.com.